Welcome to ImmuNova BioMed
The founders of ImmuNova BioMed strongly believe that cancer therapies, despite recent advances, have significant potential for improvement, aiming toward a future where cancer becomes a manageable and controllable disease. With deep expertise and extensive experience in immuno-oncology, we are particularly focused on leveraging the synergy between radiotherapy, nanotechnology and immunotherapy. By combining radiation oncology with tumor immunology, we are pioneering a first-in-class, durable cancer treatment through a cutting-edge multimodular approach.
ImmuNova BioMed is committed to advancing immunotherapy through several immunothechnologies including cutting-edge nanotechnology, photodynamic therapy and innate immune system activation. We develop such immunotherapies and immunomodulators to enhance not only the body’s natural immune response against cancer but also to generate specific tumor-targeting memory-forming adaptive immune cells, thereby providing safe, more effective, and prolonged personalized treatment options.
Our Mission
To create transformative, immune-based therapies for cancer patients by combining clinically meaningful immunotherapeutics that target a broad spectrum of cancer types. Our approach integrates rational immune system modulation, enhancement of anti-tumor responses, and smart strategies for effective tumor eradication.
Our Vision
To offer patients around the world safe, life-improving immunotherapies. We empower the body’s own immune system to recognize and eliminate cancer through expertly designed, patient-tailored agents that guide and enhance immune activity with precision and care.
